Cargando…

ABO blood groups and the risk of SARS-CoV-2 infection

There is no doubt that genetic factors of the host play a role in susceptibility to infectious diseases. An association between ABO blood groups and SARS-CoV-2 infection as well as the severity of COVID-19 has been suggested relatively early during the pandemic and gained enormously high public inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Bullerdiek, Jörn, Reisinger, Emil, Rommel, Birgit, Dotzauer, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973646/
https://www.ncbi.nlm.nih.gov/pubmed/35364749
http://dx.doi.org/10.1007/s00709-022-01754-1
_version_ 1784680083184680960
author Bullerdiek, Jörn
Reisinger, Emil
Rommel, Birgit
Dotzauer, Andreas
author_facet Bullerdiek, Jörn
Reisinger, Emil
Rommel, Birgit
Dotzauer, Andreas
author_sort Bullerdiek, Jörn
collection PubMed
description There is no doubt that genetic factors of the host play a role in susceptibility to infectious diseases. An association between ABO blood groups and SARS-CoV-2 infection as well as the severity of COVID-19 has been suggested relatively early during the pandemic and gained enormously high public interest. It was postulated that blood group A predisposes to a higher risk of infection as well as to a much higher risk of severe respiratory disease and that people with blood group O are less frequently and less severely affected by the disease. However, as to the severity of COVID-19, a thorough summary of the existing literature does not support these assumptions in general. Accordingly, at this time, there is no reason to suppose that knowledge of a patient’s ABO phenotype should directly influence therapeutical decisions in any way. On the other hand, there are many data available supporting an association between the ABO blood groups and the risk of contracting SARS-CoV-2. To explain this association, several interactions between the virus and the host cell membrane have been proposed which will be discussed here. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00709-022-01754-1.
format Online
Article
Text
id pubmed-8973646
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-89736462022-04-01 ABO blood groups and the risk of SARS-CoV-2 infection Bullerdiek, Jörn Reisinger, Emil Rommel, Birgit Dotzauer, Andreas Protoplasma Review There is no doubt that genetic factors of the host play a role in susceptibility to infectious diseases. An association between ABO blood groups and SARS-CoV-2 infection as well as the severity of COVID-19 has been suggested relatively early during the pandemic and gained enormously high public interest. It was postulated that blood group A predisposes to a higher risk of infection as well as to a much higher risk of severe respiratory disease and that people with blood group O are less frequently and less severely affected by the disease. However, as to the severity of COVID-19, a thorough summary of the existing literature does not support these assumptions in general. Accordingly, at this time, there is no reason to suppose that knowledge of a patient’s ABO phenotype should directly influence therapeutical decisions in any way. On the other hand, there are many data available supporting an association between the ABO blood groups and the risk of contracting SARS-CoV-2. To explain this association, several interactions between the virus and the host cell membrane have been proposed which will be discussed here. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00709-022-01754-1. Springer Vienna 2022-04-01 2022 /pmc/articles/PMC8973646/ /pubmed/35364749 http://dx.doi.org/10.1007/s00709-022-01754-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Bullerdiek, Jörn
Reisinger, Emil
Rommel, Birgit
Dotzauer, Andreas
ABO blood groups and the risk of SARS-CoV-2 infection
title ABO blood groups and the risk of SARS-CoV-2 infection
title_full ABO blood groups and the risk of SARS-CoV-2 infection
title_fullStr ABO blood groups and the risk of SARS-CoV-2 infection
title_full_unstemmed ABO blood groups and the risk of SARS-CoV-2 infection
title_short ABO blood groups and the risk of SARS-CoV-2 infection
title_sort abo blood groups and the risk of sars-cov-2 infection
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973646/
https://www.ncbi.nlm.nih.gov/pubmed/35364749
http://dx.doi.org/10.1007/s00709-022-01754-1
work_keys_str_mv AT bullerdiekjorn abobloodgroupsandtheriskofsarscov2infection
AT reisingeremil abobloodgroupsandtheriskofsarscov2infection
AT rommelbirgit abobloodgroupsandtheriskofsarscov2infection
AT dotzauerandreas abobloodgroupsandtheriskofsarscov2infection